http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0170688-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44e0905262f429c7590b40df8448c0c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_397edef248880d4b55a6cfa77a9e8775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6dc66b08ec5965426acd3c364c53288 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45c0d9778a93d12ff3076fb3d349b818 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-94 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-88 |
| filingDate | 2001-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39896601bbcba84bcce2be5a0166e60d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fbe90e5b122663f7cc684adf2ab79a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26793309c49cf0702de1b3e17261e820 |
| publicationDate | 2001-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-0170688-A2 |
| titleOfInvention | N-(2,6-dioxo-piperidin-3-yl) benzamides and their use as immune modulators |
| abstract | The invention relates to substituted benzamides of formula (I), wherein R<1> represents a group of formula COOR<4> wherein R<4> represents a straight-chained or branched alkyl radical with 1-6 C atoms or a group of formula CONR<5>R<6> wherein R<5> and R<6> are the same or different and mean an alkyl group with 1-6 C-atoms (straight-chained or branched) or together with the N-atom, mean a pyrrolidine, piperidine, hexamethyleneimine or morpholine ring; R<2> means chlorine, fluorine, CF3, an alkyl radical with 1-3 C-atoms or hydrogen and R<3> represents the hydroxy group, an alkyl or alkoxy radical with 1-6 C-atoms (straight-chained or branched and optionally substituted with OH-, alkoxy, ester or amide groups) or a radical CH2-NR<5>R<6> wherein R<5> and R<6> are defined as above; characterised in that R<1> represents a group of formula COR<4> wherein R<4> is defined as above and/or R<2> represents the amino group. The invention also relates to the use of the substituted benzamides as medicaments, especially as immune modulators. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2862643-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2862642-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005054192-A1 |
| priorityDate | 2000-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.